Published in Gene Therapy Weekly, November 4th, 1996
The response is further enhanced by the inclusion of a vitamin D3 adjuvant. The results were presented at IBC's 4th Annual International Conference on Mucosal Immunization, Genetic Approaches & Adjuvants, held in Washington, D.C., in October 1996.
"One of the major concerns raised regarding early nucleic acid delivery systems involved the use of non-specific viral promoters, which could activate systemic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.